You do realize anyone trying to follow what you say is impossible because all your posts contradict each other. Not one or two, but all of them. Everything you are saying now you should have know last year when you were pumping the hell out of the stock trying to mislead investors.
If you did buy a "ton" in the .02's and totally changed your mind 'yet gain', then why don't you take your triple profit and move on? It is because that is also BS like all your other posts?
Funny you even have to thumbs up your own posts as no one else would be up at that hour in the morning to read this crap. There is another board for people with anger management issues. They are lonely over there and would appreciate having a 3rd person to share their "feelings" with. They may even let you pet the emotional therapy squirrel too.
If you did buy a "ton" in the .02's and totally changed your mind 'yet gain', then why don't you take your triple profit and move on? It is because that is also BS like all your other posts?
Funny you even have to thumbs up your own posts as no one else would be up at that hour in the morning to read this crap. There is another board for people with anger management issues. They are lonely over there and would appreciate having a 3rd person to share their "feelings" with. They may even let you pet the emotional therapy squirrel too.
Quote:and after my review, I frankly do not believe their patent portfolio even sufficiently protects MANF.
Quote:09/10/2017
I am in it for the long haul based on the stacks of supportive research on MANF across multiple gene therapy indications. If I lose, my investment was based on sound research, both from the scientific and financial side. I have been buying tons of shares for over a year now in the .02s
Read More: https://investorshangout.com/post/view?id=473...z59uiciz2y
Quote:09/08/2017 4:04:39 PM
Wow. Maybe the market is finally waking up to what AMBS is holding here in gene therapy . $VYGR MANF.
Read More: https://investorshangout.com/post/view?id=473...z59ui9eRGB
Quote:09/08/2017 10:55:47 AM
Freaking MANF was written up in 'Nature' last year for retinitis pigmentosa. 'Nature' for goodness sake! And we all already know about it's
potential in Parkinson's and other diseases. Patience. I predict a very lucrative bidding war eventually for the MANF IP. Who knows? Maybe AMBS even gets a stake. It is perhaps the most promising compound in all of gene therapy.
Read More: https://investorshangout.com/post/view?id=473...z59uiKU2Cy
4
